Literature DB >> 11128014

Design criteria for rigid rocker shoes.

C van Schie1, J S Ulbrecht, M B Becker, P R Cavanagh.   

Abstract

In this study nine different rigid rocker shoe designs were tested in 17 symptom-free male subjects and compared with the control condition of a flexible, non-rockered extra-depth shoe with the same flat insole. Effects of both rocker height and axis location were explored. Peak pressure was reduced at most forefoot locations by rocker shoes, but increased in the midfoot and heel. Axis location was found to have an important effect, particularly on hallux pressures. On average the best axis location for reducing metatarsal head (MTH) pressure was in the region of 55-60% of shoe length, while for the toes it was 65%. There was a mean trend towards optimal reduction of pressure in one of the rocker shoe conditions at each anatomical location, but the axis position for this optimal placement was variable across subjects and anatomical locations. While most configurations of the rocker shoes were superior to the control shoe, no single configuration was optimal for all subjects at all sites or even for all subjects at the same site. Therefore, some form of plantar pressure measurement in conjunction with gait training to ensure correct use of the rocker shoes would appear to be essential if the pressure reducing effect of the rigid rocker bottom shoe is to be optimized.

Mesh:

Year:  2000        PMID: 11128014     DOI: 10.1177/107110070002101007

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  12 in total

1.  Biomechanics of the double rocker sole shoe: gait kinematics and kinetics.

Authors:  J T Long; N Sirota; J P Klein; J J Wertsch; D Janisse; G F Harris
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2004

Review 2.  [Conservative treatment of hallux valgus : What can be achieved with splints and insoles?]

Authors:  R A Fuhrmann; W Rippel; A Traub
Journal:  Orthopade       Date:  2017-05       Impact factor: 1.087

3.  Effect of rocker shoe radius on oxygen consumption rate in young able-bodied persons.

Authors:  Andrew H Hansen; Charles C Wang
Journal:  J Biomech       Date:  2011-03-02       Impact factor: 2.712

4.  The effect of toe-only rocker sole shoes on gait variability of the elderly.

Authors:  Fatemeh Hemmati; Mohammad Taghi Karimi; Seyed Iman Hosseini; Mohammad Ali Mardani; Reza Fadayevatan
Journal:  Med Biol Eng Comput       Date:  2022-06-20       Impact factor: 3.079

5.  Evaluation and optimization of therapeutic footwear for neuropathic diabetic foot patients using in-shoe plantar pressure analysis.

Authors:  Sicco A Bus; Rob Haspels; Tessa E Busch-Westbroek
Journal:  Diabetes Care       Date:  2011-05-24       Impact factor: 19.112

6.  The effect of rollover footwear on the rollover function of walking.

Authors:  Saeed Forghany; Christopher J Nester; Barry Richards
Journal:  J Foot Ankle Res       Date:  2013-07-09       Impact factor: 2.303

7.  Stiffness Effects in Rocker-Soled Shoes: Biomechanical Implications.

Authors:  Shih-Yun Lin; Pei-Fang Su; Chia-Hua Chung; Chi-Chun Hsia; Chih-Han Chang
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

8.  Optimisation of rocker sole footwear for prevention of first plantar ulcer: comparison of group-optimised and individually-selected footwear designs.

Authors:  Stephen J Preece; Jonathan D Chapman; Bjoern Braunstein; Gert-Peter Brüggemann; Christopher J Nester
Journal:  J Foot Ankle Res       Date:  2017-07-06       Impact factor: 2.303

9.  State of the art design protocol for custom made footwear for people with diabetes and peripheral neuropathy.

Authors:  Sicco A Bus; Jennefer B Zwaferink; Rutger Dahmen; Tessa Busch-Westbroek
Journal:  Diabetes Metab Res Rev       Date:  2019-12-16       Impact factor: 4.876

10.  Do orthopaedic shoes improve local dynamic stability of gait? An observational study in patients with chronic foot and ankle injuries.

Authors:  Philippe Terrier; François Luthi; Olivier Dériaz
Journal:  BMC Musculoskelet Disord       Date:  2013-03-14       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.